Pfizer Inc (PFE)

$26.44 +0.34 (1.30%)
Market Cap 148.40B
Revenue (ttm) 63.63B
Net Income (ttm) 8.03B
EPS (ttm) N/A
PE Ratio 8.08
Forward PE 8.72
Profit Margin 12.62%
Debt to Equity Ratio 0.66
Volume 51,599,400
Avg Vol 48,810,688
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 78%
Beta 0.47
Analysts Sell
Price Target $28.43

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and tre...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
parcha
parcha Jan. 31 at 12:25 AM
$WDC $PFE On Tuesday, we’ll get the latest from names including Pfizer , Pepsi , Merck , Advanced Micro Devices , and Chipotle . While investors will look to AMD for insights into the AI boom, Cramer said it’s possible that even a terrific set of numbers will be met with selling. That’s seemingly become “the new pattern” for chip stocks, he said. Also Tuesday, Western Digital is hosting what it’s dubbed an innovation day, where the company plans to highlight innovations aimed at supporting growing data storage demand. Cramer said the upcoming event is “critical” after the company’s stock got crushed Friday despite posting a great quarter the prior evening. “We have to find out what that’s about,” he said. https://www.cnbc.com/2026/01/30/cramers-week-ahead-earnings-eli-lilly-alphabet-amazon-jobs-data.html
0 · Reply
Narko
Narko Jan. 30 at 11:28 PM
$PINS $PFE buying another 5k shares each on Monday. I think they both beat earnings
1 · Reply
Tiger65
Tiger65 Jan. 30 at 11:17 PM
$PFE a strong earnings reaction is to be expected on Tuesday. Big chance to finally overcome the two year resistance line.
0 · Reply
Lord_Andrew_London
Lord_Andrew_London Jan. 30 at 9:27 PM
$PFE When technology collapse this Will fly.....it's about time. So much embedded real value Here. Strong buy
1 · Reply
Willieberich
Willieberich Jan. 30 at 9:24 PM
$PFE safe haven assets are up .money that moved into khc stock up also .holding onto both . Good luck people.
0 · Reply
StockHunter75
StockHunter75 Jan. 30 at 8:46 PM
$PFE I like this going into february.
0 · Reply
Stonehere
Stonehere Jan. 30 at 8:44 PM
$PFE going to $30 next week!
0 · Reply
TopazFrenzy
TopazFrenzy Jan. 30 at 8:13 PM
$PFE Stable as they come in this changing market
0 · Reply
gigafactory
gigafactory Jan. 30 at 7:34 PM
$PFE holding Pfizer since Nov 2024. my cost basis evened out today. should I sell ?
1 · Reply
CuriouslyPanda
CuriouslyPanda Jan. 30 at 7:31 PM
$PFE Holding shares & hedging with $25.50 PUTS for 2/26 We'll all seen this 100 times already.
0 · Reply
Latest News on PFE
Pfizer: Buyer Beware, The Risk Outweighs The Reward

Jan 30, 2026, 10:31 AM EST - 12 hours ago

Pfizer: Buyer Beware, The Risk Outweighs The Reward

Why Dividend Stocks Are Essential For What Comes Next

Jan 30, 2026, 7:30 AM EST - 15 hours ago

Why Dividend Stocks Are Essential For What Comes Next

AM CAG EPD ET KMI LLY MPLX

Pfizer: A High-Yield Pharma At A Turning Point

Jan 29, 2026, 9:00 AM EST - 1 day ago

Pfizer: A High-Yield Pharma At A Turning Point

US Medicare names Eli Lilly, Pfizer and AbbVie drugs for next Medicare price talks

Jan 27, 2026, 4:52 PM EST - 3 days ago

US Medicare names Eli Lilly, Pfizer and AbbVie drugs for next Medicare price talks

ABBV LLY

Pfizer vs. Merck Stock And JNJ

Jan 27, 2026, 7:40 AM EST - 3 days ago

Pfizer vs. Merck Stock And JNJ

Pfizer: The Great Healthcare Plan Does Not Change My Bullish Stance

Jan 27, 2026, 6:02 AM EST - 3 days ago

Pfizer: The Great Healthcare Plan Does Not Change My Bullish Stance

Pfizer: Expect Another Double Beating For Q1 (Earnings Preview)

Jan 23, 2026, 10:33 AM EST - 7 days ago

Pfizer: Expect Another Double Beating For Q1 (Earnings Preview)

December Readers ID'd 9 Ideal 'Safer' Dividends In 40 Dogs

Jan 23, 2026, 9:54 AM EST - 7 days ago

December Readers ID'd 9 Ideal 'Safer' Dividends In 40 Dogs

AGNC AGNCP ARLP ECC EFC ET FBRT

Pfizer CEO Albert Bourla: U.S. drug prices are coming down

Jan 20, 2026, 12:34 PM EST - 10 days ago

Pfizer CEO Albert Bourla: U.S. drug prices are coming down

Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry

Jan 20, 2026, 12:18 PM EST - 10 days ago

Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry

NVO

Novavax enters license agreement with Pfizer for vaccine development

Jan 20, 2026, 7:11 AM EST - 10 days ago

Novavax enters license agreement with Pfizer for vaccine development

NVAX

Japan's Shionogi boosts ViiV stake to 21.7% as Pfizer exits

Jan 20, 2026, 2:19 AM EST - 10 days ago

Japan's Shionogi boosts ViiV stake to 21.7% as Pfizer exits

Invesco Equity And Income Fund Q4 2025 Portfolio Positioning And Performance

Jan 19, 2026, 8:10 PM EST - 11 days ago

Invesco Equity And Income Fund Q4 2025 Portfolio Positioning And Performance

BDX DD MSFT ORCL PH Q SLB

MoneyShow's Best Investment Ideas For 2026: Part 7

Jan 19, 2026, 2:20 PM EST - 11 days ago

MoneyShow's Best Investment Ideas For 2026: Part 7

PLD PLG PM QUIK RCAT

Pfizer: Rebound Has Just Started

Jan 16, 2026, 1:08 PM EST - 14 days ago

Pfizer: Rebound Has Just Started

Pfizer: The Most Intriguing Value Play Of 2026

Jan 15, 2026, 8:58 AM EST - 15 days ago

Pfizer: The Most Intriguing Value Play Of 2026

Pfizer's Patent Cliff, Rising Debt, And The Fight To Stay A Buy

Jan 13, 2026, 6:11 AM EST - 17 days ago

Pfizer's Patent Cliff, Rising Debt, And The Fight To Stay A Buy

Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra

Jan 12, 2026, 6:43 PM EST - 18 days ago

Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra

Pfizer Inc. (PFE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 3:16 PM EST - 18 days ago

Pfizer Inc. (PFE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Pfizer's BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer

Jan 10, 2026, 10:00 AM EST - 20 days ago

Pfizer's BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer

Healthy Returns: What to expect from pharma at the JPM conference

Jan 9, 2026, 12:57 PM EST - 21 days ago

Healthy Returns: What to expect from pharma at the JPM conference

AMGN AZN BMY LLY MRK NVO

Gordian Bio Announces Research Collaboration with Pfizer to Accelerate In Vivo Target Discovery in Obesity

Jan 8, 2026, 8:00 AM EST - 22 days ago

Gordian Bio Announces Research Collaboration with Pfizer to Accelerate In Vivo Target Discovery in Obesity

Trial Date Has Been Set in MDL against Pfizer for Depo-Provera Overseen by Levin Papantonio

Jan 7, 2026, 2:16 PM EST - 23 days ago

Trial Date Has Been Set in MDL against Pfizer for Depo-Provera Overseen by Levin Papantonio

Quant Q&A With Steven Cress

Jan 7, 2026, 7:00 AM EST - 23 days ago

Quant Q&A With Steven Cress

CLS CRDO ET FIX MRK

America's new vaccine doctrine for children replaces data with dogma

Jan 6, 2026, 11:55 AM EST - 24 days ago

America's new vaccine doctrine for children replaces data with dogma

MRNA

Cartography Biosciences and Pfizer to Collaborate on the Discovery of Tumor-Selective Antigens

Jan 6, 2026, 7:30 AM EST - 24 days ago

Cartography Biosciences and Pfizer to Collaborate on the Discovery of Tumor-Selective Antigens

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Jan 5, 2026, 10:00 AM EST - 25 days ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer 2026: The Reset Year

Jan 2, 2026, 2:52 PM EST - 4 weeks ago

Pfizer 2026: The Reset Year

3 ultra-high-yield stocks to consider for $300 of dividend income in 2026

Dec 31, 2025, 8:37 AM EST - 4 weeks ago

3 ultra-high-yield stocks to consider for $300 of dividend income in 2026

AGNC PFLT

Exclusive: Drugmakers raise US prices on 350 medicines despite pressure from Trump

Dec 31, 2025, 6:08 AM EST - 4 weeks ago

Exclusive: Drugmakers raise US prices on 350 medicines despite pressure from Trump

GSK LLY NVS SNY

Chevron, Kimberly-Clark Among 16 Companies To Kick Off 2026 With Annual Dividend Increases In January

Dec 26, 2025, 10:35 PM EST - 4 weeks ago

Chevron, Kimberly-Clark Among 16 Companies To Kick Off 2026 With Annual Dividend Increases In January

CVX KMB ABM ABT AMGN AVGO BCPC

Pfizer says patient dies after receiving hemophilia drug in trial

Dec 23, 2025, 11:24 AM EST - 5 weeks ago

Pfizer says patient dies after receiving hemophilia drug in trial

Pfizer Isn't Dead Money, Pipeline Execution Can Spark A Rebound

Dec 19, 2025, 11:45 AM EST - 6 weeks ago

Pfizer Isn't Dead Money, Pipeline Execution Can Spark A Rebound

Trump to announce new drug-pricing deals later today

Dec 19, 2025, 10:45 AM EST - 6 weeks ago

Trump to announce new drug-pricing deals later today

ABBV AMGN AZN BMY GILD LLY MRK

Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts

Dec 18, 2025, 10:00 AM EST - 6 weeks ago

Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts

Pfizer Plays Catchup In Obesity Market, Licenses Weight-loss Drug From Fosun

Dec 18, 2025, 6:58 AM EST - 6 weeks ago

Pfizer Plays Catchup In Obesity Market, Licenses Weight-loss Drug From Fosun

AbbVie, several other pharma companies near MFN deal with Trump, sources say

Dec 17, 2025, 4:11 PM EST - 6 weeks ago

AbbVie, several other pharma companies near MFN deal with Trump, sources say

ABBV AMGN AZN BMY LLY NVS

Pfizer Stock Can Sink More. Here Is How

Dec 17, 2025, 2:36 PM EST - 6 weeks ago

Pfizer Stock Can Sink More. Here Is How

Pfizer, Merck Are Boring Again — And That's Exactly Why 2026 Investors Are Circling Back

Dec 17, 2025, 10:14 AM EST - 6 weeks ago

Pfizer, Merck Are Boring Again — And That's Exactly Why 2026 Investors Are Circling Back

MRK

PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Dec 17, 2025, 6:45 AM EST - 6 weeks ago

PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript

Dec 16, 2025, 2:39 PM EST - 6 weeks ago

Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript

Pfizer falls on disappointing guidance

Dec 16, 2025, 12:33 PM EST - 6 weeks ago

Pfizer falls on disappointing guidance

Pfizer's modest 2026 outlook shows its big investments will take time to pay off

Dec 16, 2025, 10:12 AM EST - 6 weeks ago

Pfizer's modest 2026 outlook shows its big investments will take time to pay off

Here's why Pfizer is revising its revenue forecasts

Dec 16, 2025, 7:47 AM EST - 6 weeks ago

Here's why Pfizer is revising its revenue forecasts

Pfizer Stock Edges Higher on 2026 Guidance. Expect a Rough Year for Covid Vaccine Sales.

Dec 16, 2025, 7:25 AM EST - 6 weeks ago

Pfizer Stock Edges Higher on 2026 Guidance. Expect a Rough Year for Covid Vaccine Sales.

Pfizer Expects Decline in Covid-19 Drug Demand to Hurt 2026 Earnings

Dec 16, 2025, 7:16 AM EST - 6 weeks ago

Pfizer Expects Decline in Covid-19 Drug Demand to Hurt 2026 Earnings

Pfizer forecasts 2026 profit below expectations on lower COVID product sales

Dec 16, 2025, 6:54 AM EST - 6 weeks ago

Pfizer forecasts 2026 profit below expectations on lower COVID product sales

Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance

Dec 16, 2025, 6:45 AM EST - 6 weeks ago

Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance

Adaptive Biotechnologies signs non-exclusive deals with Pfizer worth up to $890 million

Dec 15, 2025, 8:24 AM EST - 6 weeks ago

Adaptive Biotechnologies signs non-exclusive deals with Pfizer worth up to $890 million

ADPT

Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer

Dec 15, 2025, 8:00 AM EST - 6 weeks ago

Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer

ADPT

parcha
parcha Jan. 31 at 12:25 AM
$WDC $PFE On Tuesday, we’ll get the latest from names including Pfizer , Pepsi , Merck , Advanced Micro Devices , and Chipotle . While investors will look to AMD for insights into the AI boom, Cramer said it’s possible that even a terrific set of numbers will be met with selling. That’s seemingly become “the new pattern” for chip stocks, he said. Also Tuesday, Western Digital is hosting what it’s dubbed an innovation day, where the company plans to highlight innovations aimed at supporting growing data storage demand. Cramer said the upcoming event is “critical” after the company’s stock got crushed Friday despite posting a great quarter the prior evening. “We have to find out what that’s about,” he said. https://www.cnbc.com/2026/01/30/cramers-week-ahead-earnings-eli-lilly-alphabet-amazon-jobs-data.html
0 · Reply
Narko
Narko Jan. 30 at 11:28 PM
$PINS $PFE buying another 5k shares each on Monday. I think they both beat earnings
1 · Reply
Tiger65
Tiger65 Jan. 30 at 11:17 PM
$PFE a strong earnings reaction is to be expected on Tuesday. Big chance to finally overcome the two year resistance line.
0 · Reply
Lord_Andrew_London
Lord_Andrew_London Jan. 30 at 9:27 PM
$PFE When technology collapse this Will fly.....it's about time. So much embedded real value Here. Strong buy
1 · Reply
Willieberich
Willieberich Jan. 30 at 9:24 PM
$PFE safe haven assets are up .money that moved into khc stock up also .holding onto both . Good luck people.
0 · Reply
StockHunter75
StockHunter75 Jan. 30 at 8:46 PM
$PFE I like this going into february.
0 · Reply
Stonehere
Stonehere Jan. 30 at 8:44 PM
$PFE going to $30 next week!
0 · Reply
TopazFrenzy
TopazFrenzy Jan. 30 at 8:13 PM
$PFE Stable as they come in this changing market
0 · Reply
gigafactory
gigafactory Jan. 30 at 7:34 PM
$PFE holding Pfizer since Nov 2024. my cost basis evened out today. should I sell ?
1 · Reply
CuriouslyPanda
CuriouslyPanda Jan. 30 at 7:31 PM
$PFE Holding shares & hedging with $25.50 PUTS for 2/26 We'll all seen this 100 times already.
0 · Reply
doubleuptwice
doubleuptwice Jan. 30 at 7:28 PM
$PFE 👀@PFElinepfrenzy1990
1 · Reply
Willieberich
Willieberich Jan. 30 at 7:08 PM
$PFE nice move !
0 · Reply
doubleuptwice
doubleuptwice Jan. 30 at 7:00 PM
$PFE volume ramping up $26.50 close?
0 · Reply
barnml2006
barnml2006 Jan. 30 at 6:18 PM
$PFE This is a good time to load up on puts. 25 put options , yes please.
0 · Reply
doubleuptwice
doubleuptwice Jan. 30 at 5:04 PM
$PFE weird how I always show up on Green Day’s before the move huh?
0 · Reply
moonbul
moonbul Jan. 30 at 5:00 PM
$PFE in a sea of red, this stands green
1 · Reply
HarrisMint
HarrisMint Jan. 30 at 4:34 PM
$PFE .PFE260130C26
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Jan. 30 at 4:17 PM
$PFE Pfizer (NYSE: PFE) announced positive results from Cohort 3 of the pivotal BREAKWATER trial evaluating BRAFTOVI in combination with cetuximab and FOLFIRI in patients with previously untreated BRAF V600E-mutant metastatic colorectal cancer. The combination achieved a confirmed objective response rate of 64.4% compared to 39.2% with standard-of-care treatment, representing a statistically significant improvement. "These data further strengthen the potential utility of BRAFTOVI for patients with BRAF V600E-mutant metastatic colorectal cancer. The significant improvement in response rates reflects the meaningful clinical benefit of this targeted combination therapy regimen for patients," said Jeff Legos, Chief Oncology Officer at Pfizer . "These results underscore the potential of BRAFTOVI as a standard of care for patients with this aggressive cancer." Among patients receiving the treatment regimen, 57.4% on BRAFTOVI plus cetuximab and FOLFIRI maintained response for six months ...
0 · Reply
doubleuptwice
doubleuptwice Jan. 30 at 4:14 PM
$PFE green
0 · Reply
Justrise07
Justrise07 Jan. 30 at 4:08 PM
$GUTS ok $LLY $NVO $PFE
0 · Reply
doubleuptwice
doubleuptwice Jan. 30 at 4:05 PM
$PFE pin this pin that max pain this max pain that blah blah blah. Reading charts is truly not an acquired skill by most.
0 · Reply
SeriouslyWhy
SeriouslyWhy Jan. 30 at 3:55 PM
$PFE max pain for options exp today $26 coincidence I think not
1 · Reply